Martin Madaus - Jun 15, 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
Director
Signature
/s/ Martin D. Madaus by Nicholas Khadder, Attorney-in-Fact
Stock symbol
LAB
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
4
Date filed
6/17/2022, 06:05 PM
Previous filing
Apr 6, 2022
Next filing
Aug 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock Award $0 +30.9K +195.02% $0.00 46.8K Jun 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Stock Option (Right to Buy) Award $0 +42.6K $0.00 42.6K Jun 15, 2022 Common Stock 42.6K $1.86 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders.
F2 The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022.